Behavioural and computational methods reveal differential effects for how delayed and rapid onset antidepressants effect decision making in rats

European Neuropsychopharmacology

Volumn 27, Issue 12, 2017, Pages 1268-1280

  Hales, Claire A ^a   Houghton, Conor J ^a   Robinson, Emma S J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Antidepressants; Behaviour; Diffusion model; Judgement bias; Ketamine; Rodent

Indexed keywords

AMPHETAMINE; COCAINE; FLUOXETINE; KETAMINE; PHENCYCLIDINE; REBOXETINE; VENLAFAXINE; AMINO ACID RECEPTOR BLOCKING AGENT; ANALGESIC AGENT; ANTIDEPRESSANT AGENT; CENTRAL STIMULANT AGENT;

ACUTE DRUG ADMINISTRATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; ASSOCIATION; CHRONIC DRUG ADMINISTRATION; COGNITIVE BIAS; COHORT ANALYSIS; CONTROLLED STUDY; DECISION MAKING; DIFFUSION; DOSE RESPONSE; DRUG EFFICACY; LATENT PERIOD; LONG TERM CARE; MALE; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; RESPONSE TIME; REWARD; SINGLE DRUG DOSE; ANIMAL; ASSOCIATIVE LEARNING; AUDITORY STIMULATION; BIOLOGICAL MODEL; CONDITIONED REFLEX; DISEASE MODEL; DRUG EFFECT; MAJOR DEPRESSION; REACTION TIME; TIME FACTOR;

ACOUSTIC STIMULATION; AMPHETAMINE; ANALGESICS; ANIMALS; ANTIDEPRESSIVE AGENTS; ASSOCIATION LEARNING; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; CONDITIONING, CLASSICAL; DECISION MAKING; DEPRESSIVE DISORDER, MAJOR; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; FLUOXETINE; KETAMINE; MALE; MODELS, BIOLOGICAL; PHENCYCLIDINE; RATS; REACTION TIME; TIME FACTORS;

EID: 85033670190     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2017.09.008     Document Type: Article

References (73)

1. Anderson, I.M., Nutt, D.J., Deakin, J.F.W., Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. J. Psychopharmacol. 14 (2000), 3–20.
2. Anderson, M., Hardcastle, C., Munafò, M., Robinson, E.J., Evaluation of a novel translational task for assessing emotional biases in different species. Cogn. Affect. Behav. Neurosci. 12 (2012), 373–381.
3. Anderson, M., Munafò, M., Robinson, E.J., Investigating the psychopharmacology of cognitive affective bias in rats using an affective tone discrimination task. Psychopharmacology 226 (2013), 601–613.
4. Beck, A.T., Cognitive Therapy and the Emotional Disorders. 1976, Meridian, New York.
5. Beck, A.T., The evolution of the cognitive model of depression and its neurobiological correlates. Am. J. Psychiatry 165 (2008), 969–977.
6. Belzung, C., Lemoine, M., Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression. Biol. Mood Anxiety Disord., 1, 2011, 9.
7. Benn, A., Robinson, E.S., Investigating glutamatergic mechanism in attention and impulse control using rats in a modified 5-choice serial reaction time task. PLoS One, 9, 2014, e115374.
8. Berton, O., Hahn, C.G., Thase, M.E., Are we getting closer to valid translational models for major depression?. Science 338 (2012), 75–79.
9. Browne, C.A., Lucki, I., Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants. Front. Pharmacol., 4, 2013, 161.
10. Butler, G., Mathews, A., Cognitive processes in anxiety. Adv. Behav. Res. Ther. 5 (1983), 51–62.
11. Clark, L., Chamberlain, S.R., Sahakian, B.J., Neurocognitive mechanisms in depression: implications for treatment. Annu. Rev. Neurosci. 32 (2009), 57–74.
12. Cryan, J.F., Holmes, A., The ascent of mouse: advances in modelling human depression and anxiety. Nat. Rev. Drug Discov. 4 (2005), 775–790.
13. Cryan, J.F., Slattery, D.A., Animal models of mood disorders: recent developments. Curr. Opin. Psychiatry 20 (2007), 1–7.
14. Drewniany, E., Han, J., Hancock, C., Jones, R.L., Lim, J., Nemat Gorgani, N., Sperry, J.K., Yu, H.J., Raffa, R.B., Rapid-onset antidepressant action of ketamine: potential revolution in understanding and future pharmacologic treatment of depression. J. Clin. Pharm. Ther. 40 (2015), 125–130.
15. Duman, R.S., Li, N., A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists. Philos. Trans. R. Soc. Lond. B Biol. Sci. 367 (2012), 2475–2484.
16. Duman, R.S., Li, N., Liu, R.J., Duric, V., Aghajanian, G., Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology 62 (2012), 35–41.
17. Duman, R.S., Monteggia, L.M., A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 59 (2006), 1116–1127.
18. Duman, R.S., Voleti, B., Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents. Trends Neurosci. 35 (2012), 47–56.
19. Gotlib, I.H., Joormann, J., Cognition and depression: current status and future directions. Ann. Rev. Clin. Psychol. 6 (2010), 285–312.
20. Hales, C.A., Robinson, E.S., Houghton, C.J., Diffusion Modelling reveals the decision making processes underlying negative judgement bias in rats. PLoS One, 11, 2016, e0152592.
21. Hales, C.A., Stuart, S.A., Anderson, M.H., Robinson, E.S.J., Modelling cognitive affective biases in major depressive disorder using rodents. Br. J. Pharmacol. 171 (2014), 4524–4538.
22. Harding, E.J., Paul, E.S., Mendl, M., Animal behaviour: cognitive bias and affective state. Nature, 427, 2004 (312-312).
23. Harmer, C.J., Antidepressant drug action: a neuropsychological perspective. Depress. Anxiety 27 (2010), 231–233.
24. Harmer, C.J., Bhagwagar, Z., Perrett, D.I., Vollm, B.A., Cowen, P.J., Goodwin, G.M., Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology 28 (2003), 148–152.
25. Harmer, C.J., Dawson, G.R., Dourish, C.T., Favaron, E., Parsons, E., Fiore, M., Zucchetto, M., Bifone, A., Poggesi, I., Fernandes, S., Alexander, R.C., Goodwin, G.M., Combined NK(1) antagonism and serotonin reuptake inhibition: effects on emotional processing in humans. J. Psychopharmacol. 27 (2013), 435–443.
26. Harmer, C.J., de Bodinat, C., Dawson, G.R., Dourish, C.T., Waldenmaier, L., Adams, S., Cowen, P.J., Goodwin, G.M., Agomelatine facilitates positive versus negative affective processing in healthy volunteer models. J. Psychopharmacol. 25 (2011), 1159–1167.
27. Harmer, C.J., Goodwin, G.M., Cowen, P.J., Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. Br. J. Psychiatry 195 (2009), 102–108.
28. Harmer, C.J., O'Sullivan, U., Favaron, E., Massey-Chase, R., Ayres, R., Reinecke, A., Goodwin, G.M., Cowen, P.J., Effect of acute antidepressant administration on negative affective bias in depressed patients. Am. J. Psychiatry 166 (2009), 1178–1184.
29. Harmer, C.J., Shelley, N.C., Cowen, P.J., Goodwin, G.M., Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am. J. Psychiatry 161 (2004), 1256–1263.
30. Kircanski, K., Joormann, J., Gotlib, I.H., Cognitive aspects of depression. Wiley Interdiscip. Rev. Cogn. Sci. 3 (2012), 301–313.
31. Mathews, A., MacLeod, C., Cognitive vulnerability to emotional disorders. Annu. Rev. Clin. Psychol. 1 (2005), 167–195.
32. McMillen, B.A., CNS stimulants: two distinct mechanisms of action for amphetamine-like drugs. Trends Pharmacol. Sci. 4 (1983), 429–432.
33. Murphy, F.C., Sahakian, B.J., Rubinsztein, J.S., Michael, A., Rogers, R.D., Robbins, T.W., Paykel, E.S., Emotional bias and inhibitory control processes in mania and depression. Psychol. Med. 29 (1999), 1307–1321.
34. Nestler, E.J., Gould, E., Manji, H., Buncan, M., Duman, R.S., Greshenfeld, H.K., Hen, R., Koester, S., Lederhendler, I., Meaney, M., Robbins, T., Winsky, L., Zalcman, S., Preclinical models: status of basic research in depression. Biol. Psychiatry 52 (2002), 503–528.
35. Nestler, E.J., Hyman, S.E., Animal models of neuropsychiatric disorders. Nat. Neurosci. 13 (2010), 1161–1169.
36. Newport, D.J., Carpenter, L.L., McDonald, W.M., Potash, J.B., Tohen, M., Nemeroff, C.B., Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression. Am. J. Psychiatry 172 (2015), 950–966.
37. Nunn, J.D., Mathews, A., Trower, P., Selective processing of concern-related information in depression. Br. J. Clin. Psychol. 36 (1997), 489–503.
38. O'Leary, O.F., Cryan, J.F., Towards translational rodent models of depression. Cell Tissue Res. 354 (2013), 141–153.
39. Papciak, J., Popik, P., Fuchs, E., Rygula, R., Chronic psychosocial stress makes rats more ‘pessimistic’ in the ambiguous-cue interpretation paradigm. Behav. Brain Res. 256 (2013), 305–310.
40. Paul, E.S., Cuthill, I., Kuroso, G., Norton, V., Woodgate, J., Mendl, M., Mood and the speed of decisions about anticipated resources and hazards. Evol. Hum. Behav. 32 (2011), 21–28.
41. Porsolt, R.D., Le Pichon, M., Jalfre, M., Depression: a new animal model sensitive to antidepressant treatments. Nature 266 (1977), 730–732.
42. Posternak, M.A., Zimmerman, M., Is there a delay in the antidepressant effect? A meta-analysis. J. Clin. Psychiatry 66 (2005), 148–158.
43. Rasmussen, N., Making the first anti-depressant: amphetamine in American medicine, 1929–1950. J. Hist. Med. Allied Sci. 61 (2006), 288–323.
44. Ratcliff, R., A theory of memory retrieval. Psychol. Rev. 85 (1978), 59–108.
45. Ratcliff, R., Rouder, J.N., Modeling response times for two-choice decisions. Psychol. Sci. 9 (1998), 347–356.
46. Robinson, E.S., Roiser, J.P., Affective biases in humans and animals. Curr. Top. Behav. Neurosci., 2016, 10.1007/7854_2015_5011 (e-pub ahead of print).
47. Robinson, O.J., Letkiewicz, A.M., Overstreet, C., Ernst, M., Grillon, C., The effect of induced anxiety on cognition: threat of shock enhances aversive processing in healthy individuals. Cogn. Affect. Behav. Neurosci. 11 (2011), 217–227.
48. Roiser, J.P., Elliott, R., Sahakian, B.J., Cognitive mechanisms of treatment in depression. Neuropsychopharmacology 37 (2012), 117–136.
49. Rygula, R., Papciak, J., Popik, P., Trait pessimism predicts vulnerability to stress-induced anhedonia in rats. Neuropsychopharmacology 38 (2013), 2188–2196.
50. Rygula, R., Papciak, J., Popik, P., The effects of acute pharmacological stimulation of the 5-HT, NA and DA systems on the cognitive judgement bias of rats in the ambiguous-cue interpretation paradigm. Eur. Neuropsychopharmacol. 24 (2014), 1103–1111.
51. Rygula, R., Szczech, E., Papciak, J., Nikiforuk, A., Popik, P., The effects of cocaine and mazindol on the cognitive judgement bias of rats in the ambiguous-cue interpretation paradigm. Behav. Brain Res. 270 (2014), 206–212.
52. Schick, A., Adam, R., Vollmayr, B., Kuehner, C., Kanske, P., Wessa, M., Neural correlates of valence generalization in an affective conditioning paradigm. Behav. Brain Res. 292 (2015), 147–156.
53. Schick, A., Wessa, M., Vollmayr, B., Kuehner, C., Kanske, P., Indirect assessment of an interpretation bias in humans: neurophysiological and behavioral correlates. Front. Hum. Neurosci., 7, 2013, 272.
54. Stuart, S.A., Butler, P., Munafo, M.R., Nutt, D.J., Robinson, E.S., A translational rodent assay of affective biases in depression and antidepressant therapy. Neuropsychopharmacology 38 (2013), 1625–1635.
55. Stuart, S.A., Butler, P., Munafo, M.R., Nutt, D.J., Robinson, E.S., Distinct neuropsychological mechanisms may explain delayed- versus rapid-onset antidepressant efficacy. Neuropsychopharmacology 40 (2015), 2165–2174.
56. Stuart, S.A., Robinson, E.S.J., Reducing the stress of drug administration: implications for the 3Rs. Sci. Rep., 5, 2015, 14288.
57. Teasdale, J.D., Negative thinking in depression: cause, effect, or reciprocal relationship?. Adv. Behav. Res. Ther. 5 (1983), 3–25.
58. Teasdale, J.D., Cognitive vulnerability to persistent depression. Cogn. Emot. 2 (1988), 247–274.
59. Voncken, M.J., Bogels, S.M., Peeters, F., Specificity of interpretation and judgemental biases in social phobia versus depression. Psychol. Psychother. 80 (2007), 443–453.
60. Voss, A., Nagler, M., Lerche, V., Diffusion models in experimental psychology: a practical introduction. J. Exp. Psychol. 60 (2013), 385–402.
61. Voss, A., Rothermund, K., Gast, A., Wentura, D., Cognitive processes in associative and categorical priming: a diffusion model analysis. J. Exp. Psychol.-Gen. 142 (2013), 536–559.
62. Voss, A., Rothermund, K., Voss, J., Interpreting the parameters of the diffusion model: an empirical validation. Mem. Cogn. 32 (2004), 1206–1220.
63. Voss, A., Voss, J., Fast-dm: a free program for efficient diffusion model analysis. Behav. Res. Methods 39 (2007), 767–775.
64. Voss, A., Voss, J., A fast numerical algorithm for the estimation of diffusion model parameters. J. Math. Psychol. 52 (2008), 1–9.
65. Voss, A., Voss, J., Klauer, K.C., Separating response-execution bias from decision bias: arguments for an additional parameter in Ratcliff's diffusion model. Br. J. Math. Stat. Psychol. 63 (2010), 539–555.
66. Voss, A., Voss, J., Lerche, V., Assessing cognitive processes with diffusion model analyses: a tutorial based on fast-dm-30. Front. Psychol., 6, 2015, 336.
67. Wang, J., Jing, L., Toledo-Salas, J.C., Xu, L., Rapid-onset antidepressant efficacy of glutamatergic system modulators: the neural plasticity hypothesis of depression. Neurosci. Bull. 31 (2015), 75–86.
68. White, C., Ratcliff, R., Vasey, M., McKoon, G., Dysphoria and memory for emotional material: a diffusion-model analysis. Cogn. Emot. 23 (2009), 181–205.
69. White, C.N., Ratcliff, R., Vasey, M.W., McKoon, G., Anxiety enhances threat processing without competition among multiple inputs: a diffusion model analysis. Emotion 10 (2010), 662–677.
70. Willner, P., The validity of animal models of depression. Psychopharmacol, 1984, 83.
71. Willner, P., Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52 (2005), 90–110.
72. Zanos, P., Moaddel, R., Morris, P.J., Georgiou, P., Fischell, J., Elmer, G.I., Alkondon, M., Yuan, P., Pribut, H.J., Singh, N.S., Dossou, K.S., Fang, Y., Huang, X.P., Mayo, C.L., Wainer, I.W., Albuquerque, E.X., Thompson, S.M., Thomas, C.J., Zarate, C.A. Jr., Gould, T.D., NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 533 (2016), 481–486.
73. Zarate, C.A. Jr., Singh, J.B., Carlson, P.J., Brutsche, N.E., Ameli, R., Luckenbaugh, D.A., Charney, D.S., Manji, H.K., A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch. Gen. Psychiatry 63 (2006), 856–864.